Salute e Benessere

Dante Genomics partners with Amazon Web Services (AWS) to launch groundbreaking…

Dante Genomics' early focus on whole genome sequencing provides the company with a natural competitive advantage to build large language models (LLMs) for clinical genomics. Each genome has 10,000 times more data than a traditional genetic panel and more than 20 times more data than whole exome sequencing. Dante Genomics' early focus on whole genome sequencing provides the company with a natural competitive advantage to build large language models (LLMs) for clinical genomics. Each genome has...
PR Newswire
20/09/2023

The CAR T Cell Therapy Market is projected to grow at an annualized rate of 20%…

Presently, more than 250 companies are engaged in the development of more than 1,200 early and late-stage T-cell therapies, worldwide. Several promising leads are anticipated to be commercially launched over the coming decade, following which the market is projected to grow at a substantial pace. Over 6,800 patents related to CAR-T therapies, TCR therapies and TIL therapies have been recently filed / granted, demonstrating the continued innovation in this domain. In addition, close to 440…
PR Newswire
20/09/2023

Bathroom Vanities Market to Reach US$ 80.8 billion by 2033; Smart Homes Pushing…

Increasing demand for smart vanities is expected to drive growth in the bathroom vanities market during the forecast period. Smart vanities have features including LED lighting, Bluetooth speakers, and built-in charging ports. This technology integration enhances the functionality and convenience of bathroom vanities, making them more appealing to consumers. Increasing demand for smart vanities is expected to drive growth in the bathroom vanities market during the forecast period. Smart...
PR Newswire
20/09/2023

UNIVERSAL MUSIC GROUP AND THRIVE GLOBAL LAUNCH MUSIC + HEALTH SUMMIT

The event brought together leading experts from across the fields of music, science, health & well-being, fitness and technology including legendary nine-time Grammy-winning producer, and recent author of 'The Creative Act: A Way of Being' Rick Rubin, in conversation withDean Willow Bayon Creativity, Music & Wellbeing. Panel discussions featured prominent voices from science and medicine including Dr. Lisa Miller, Dr. Daniel Levitin, Dr. Assal Habibi, Jaron Lanierand neurosurgeon and…
PR Newswire
20/09/2023

KOHLER x SR_A Create Limited-Edition Faucet to Launch at Design Miami/ 2023

MATERIALSCast as one singular, sculptural object, as opposed to a traditional finish plating processes, Formation 01 sets new expectations for the ritual of water. The faucet is crafted from Neolast, a new material exclusive to Kohler, which allows for the dramatic expression of form, a new language of shape and the saturation of color. Mounted on an escutcheon plate crafted from Kohler's signature cast iron, Formation 01 perfectly balances the future-forward design with the timeless…
PR Newswire
20/09/2023

TUMI SHOWCASES ITS NEW ALPHA COLLECTIONS THROUGH AN EXTENSION OF ITS…

This latest installment of the Essentially Beautiful campaign re-establishes TUMI's brand DNA. Bringing attention to one of the brand's most well-known and beloved collections through a new lens, TUMI highlights its product innovations, materials, and patented designs. This latest installment of theEssentially Beautifulcampaign re-establishes TUMI's brand DNA. Bringing attention to one of the brand's most well-known and beloved collections through a new lens, TUMI highlights its product...
PR Newswire
20/09/2023

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

Click here to view the custom infographic of the Genprex editorial. Click here to view the custom infographic of the Genprexeditorial. Launching Point for Revolution More than 30 million Americans struggle with rare diseases. Acomprehensive studypublished by the National Library of Medicine (NLM) states that the 1983 passage of the Orphan Drug Act (ODA), which created the Orphan Drug Designation Program, represented a launching point for a rare-disease drug-development...
PR Newswire
20/09/2023

Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel…

Partnership based on a highly protective vaccine candidate identified by Evaxion's EDEN™ platformThe collaboration will access mRNA technology from the WHO and Medicines Patent Pool's mRNA Vaccine Technology Transfer HubAfrigen responsible for the development and commercialization of the resulting mRNA vaccine in LMICs and African territoriesCOPENHAGEN, Denmark, Sept.20, 2023(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage...
Nasdaq GlobeNewswire
20/09/2023

Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

This collaboration broadens Abbott's medicines offering in emerging countries and expands an existing agreement with mAbxience, initiated in Latin America in 2018. Through this agreement, Abbott provided access to treatment options for two cutting-edge oncology biosimilars in various countries including Colombia, Chile and Peru, and in Central America. This collaboration broadens Abbott's medicines offering in emerging countries and expands an existing agreement with mAbxience, initiated in...
PR Newswire
20/09/2023

Photocure Partner Asieris announces that the First Non-Vaccine Investigational…

This study is a prospective, randomized, double-blind, placebo-controlled international multicenter Phase III clinical trial designed to evaluate the efficacy and safety of APL-1702 for the treatment of cervical HSIL. It is led by Academy Member Dr. Jinghe Lang from Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and has enrolled 402 participants. The trial met its primary endpoint, together with a robust safety profile. Comprehensive data from this study will be…
PR Newswire
20/09/2023

Sandrine Parkins Appointed as Head of Operations for Harvey Medical, a ClariMed…

In her new role, Sandrine will spearhead Harvey Medical's growing operations, focusing on project planning and delivery, resourcing, and talent management while ensuring a robust infrastructure for business processes and systems that will bolster Harvey Medical's performance and ClariMed's broader growth and efficiency. In her new role, Sandrine will spearhead Harvey Medical's growing operations, focusing on project planning and delivery, resourcing, and talent management while ensuring a...
PR Newswire
20/09/2023

Change in Orion Group's Half-Year Financial Report 2024 publication date 

ORION CORPORATIONSTOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 20 SEPTEMBER 2023 at 12.00 noon EEST Change in Orion Group's Half-Year Financial Report 2024 publication date Orion Corporation changes the publication date of its Half-Year Financial Report January–June 2024. The new publication date is Thursday 8 August 2024 (was previously Thursday 18 July 2024). The financial calendar will otherwise remain unchanged.The publication dates of the...
Nasdaq GlobeNewswire
20/09/2023

Alvotech Provides U.S. Regulatory Update on AVT02, a High-Concentration…

Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug Administration (FDA) has accepted Alvotech's resubmitted Biologics License Application (BLA) for AVT02, a high-concentration, interchangeable biosimilar candidate to Humira® (adalimumab). The FDA has also announced a Biosimilar User Fee Act (BsUFA) goal date for approval of the…
Nasdaq GlobeNewswire
20/09/2023

CMR Surgical surpasses 15,000 surgical procedures on Versius® globally as it…

The Company continues to deliver on its mission of bringing the benefits of Minimal Access Surgery (MAS) to more patients globally.The Versius ® Surgical Robotic System has now been used to perform over 15,000 surgical cases globally in more than 20 countries and across a wide range of surgical specialties including general , urological, gynaecological and thoracic .The company has recently closed an upsized...
Nasdaq GlobeNewswire
20/09/2023

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant

Addex led consortium wins Eurostars grant to deliver clinical candidates to treatmild neurocognitive disorders Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, September 20, 2023 - Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has led a consortium which has been awarded a €4 million Eurostars grant to...
Nasdaq GlobeNewswire
20/09/2023

Only 14% of women think they're resilient: new song featuring Melanie C shares…

Non-white women are more likely to call themselves resilient – at 2 in 10 (20%), compared to 14% of white women. They attribute this to feeling stronger after tough past experiences, having a strong faith, and a 'never give up' attitude, amongst other reasons. Non-white women are more likely to call themselves resilient – at 2 in 10 (20%), compared to 14% of white women. They attribute this to feeling stronger after tough past experiences, having a strong faith, and a 'never give up'…
PR Newswire
20/09/2023

Niemann-Pick Disease Type C Market to Proliferate by 2032, Predicts DelveInsight…

Key Takeaways from the Niemann-Pick Disease Type C Market Report Key Takeaways from the Niemann-Pick Disease Type C Market Report Discover which therapies are expected to grab the major Niemann-Pick disease type C market share @Niemann-Pick Disease Type C Market Report Niemann-Pick Disease Type C Overview Niemann-Pick disease type C is a rare progressive hereditary condition defined by the body's inability to transport cholesterol and other fatty substances into cells...
PR Newswire
19/09/2023

A NeverEnding Color Story

Unlike conventional color pool lights that only provide a handful of primary colors, the Infinite lights provide a full selection of shades along with 10 traditional pre-set colors and five light shows. Plus, Jandy revolutionizes the way color lighting works by eliminating color "cycling" with new technology that allows for instant color change—either through the iAquaLink® app or by simply asking Alexa aloud. Unlike conventional color pool lights that only provide a handful of primary…
PR Newswire
19/09/2023

Nanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023

Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST on September 27, 2023 PARIS and CAMBRIDGE, Mass., Sept.19, 2023(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial results for half-year ending June 30, 2023, on Tuesday, September 26, 2023, after...
Nasdaq GlobeNewswire
19/09/2023

Galapagos appoints Simon Sturge to its Board of Directors

Mechelen, Belgium;19 September 2023,22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announcedthat during its meeting of 19 September2023 , the Board of Directors appointedMr. Simon Sturge as Non-Executive Independent Director by way of cooptation . Mr. Sturge replaces Dr. Mary Kerr who stepped downon 18 September2023 . Mr. Sturge brings over 40 years of international biotech and pharma experience with...
Nasdaq GlobeNewswire
19/09/2023

Pancreatic Cancer Battle Boosted by $200M VC Firm

According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic cancer increased by 1% from the previous year to 12%. Back when his father passed away in 2011, Reed Jobs was studying at Stanford Universityto become a doctor. However, after the loss, Reed went on to join his mother at the impact investing and philanthropic organization formed by his mother called Emerson Collective. Unlike that organization, Yosemite will run as a…
PR Newswire
19/09/2023

Sobi publishes the final outcome of the rights issue

As a result of the rights issue, Sobi will receive proceeds amounting to approximately SEK 6,024 million before issue costs. Through the rights issue, Sobi's share capital will increase by SEK 23,275,903.56, from SEK 170,832,200.70 to SEK 194,108,104.26 and the total number of shares in Sobi will increase by 42,419,668. After the rights issue, the number of shares in Sobi will amount to 353,756,464, all of which are common shares.[1] As a result of the rights issue, Sobi will receive proceeds...
PR Newswire
19/09/2023

The opportunity within the Exosome Therapy Market to grow at 41% CAGR till 2040…

In recent years, therapies utilizing extracellular vesicles have garnered significant attention among the industry stakeholders for the treatment of diverse indications, primarily owing to the various benefits offered by them, including target specificity, enhanced tissue regeneration, and reduced inflammation and chronic pain. Over time, various research studies have demonstrated the potential of exosomes (membrane bound extracellular vesicles) in disease diagnosis, drug delivery and…
PR Newswire
19/09/2023

Fagron completes share buy-back program

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 19 September 2023 – 6PM CET Fagron completes share buy-back program Fagron has successfully completed its share buy-back program today. In the last period, from 18 September 2023 through 19 September 2023, Fagron purchased 17,266 of its owns shares at an average price of €16.12 per share corresponding to a total amount of €277,612.81. A total of 138,372 Fagron shares have been repurchased under the buy-back program...
Nasdaq GlobeNewswire
19/09/2023
Altri  Comunicati